Skip to main content
Premium Trial:

Request an Annual Quote

SBRI Enlists CombiMatrix s Array, RNA Tech for Infectious-Disease Research

NEW YORK, Oct. 9 (GenomeWeb News) - CombiMatrix will collaborate with researchers at the Seattle Biomedical Research Institute to study how the company's RNA technology and microarray platform may contribute to infectious disease research, the partners said today.

The agreement calls for SBRI scientists to use CombiMatrix's microarrays in their study of differential gene regulation of the Leishmania parasite lifecycle, the company said.

In addition, the school will use CombiMatrix's RNA technology to develop pools of RNAi compounds to silence multiple genes in Trypasonoma brucei, Trypanosoma cruzi, and Leishmania major.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.